Birmingham, West Midlands -- (SBWIRE) -- 10/09/2013 -- Value Penny Stocks issues special report on Alkaline Water Company Inc(OTCBB:WTER) , North American Oil & Gas Corp(OTCBB:NAMG), Cellceutix Corp(OTCMKTS:CTIX) , AMARANTUS BIOSCIENCE HOLDINGS, INC.(OTCBB:AMBS)
Alkaline Water Company Inc(OTCBB:WTER) managed to keep its gain at 7.68% on below-normal volume of 549,455.00 shares. The stock settled at $0.533 after floating in a range of $0.50 to $0.54. Its latest price was $0.533, reaching market capitalization of $42.31 million. Its 52-week range has been 0.04 to $1.30. The Alkaline Water Company Inc. engages in the production, distribution, marketing, and selling bottled alkaline water in bulk for retail sale. The company offers bottled alkaline water to retail consumers in three-liter and one-gallon volumes under the Alkaline84 brand.
What was the Moving Force behind WTER On Bullish Run? Read This Research Report on WTER
North American Oil & Gas Corp(OTCBB:NAMG) traded up on a volume of 527,461.00, higher than its standard daily volume. Shares have gained 4.49% to $0.930. Over the last twelve months, the stock has added 272% and faced a best price of $0.25. North American Oil & Gas Corp. offers oil and gas production services. The company was founded in 2011 and is based in Ventura, California.
For How Long NAMG will Fight for Profitability? Read This Trend Analysis report
Cellceutix Corp(OTCMKTS:CTIX) settled -4.52% lower at $1.69 on above-normal volume of 265,578.00 shares during the last trading day. The stock has its 12-month high at $1.78 and 52-week low price was $0.77. It traded in a range of $1.68 to $1.78 during the last trading day. Cellceutix Corporation, a development stage biopharmaceutical company, engages in the discovery and development of small molecule drugs to treat diseases primarily in the areas of cancer and inflammatory disease.
Why Should Investors Buy CTIX After the Recent Fall ? Just Go Here and Find Out
AMARANTUS BIOSCIENCE HOLDINGS, INC.(OTCBB:AMBS) saw its price fall on volume, as 4.44 million shares changed hands when compared with its average daily volume of 1.11 million shares. The stock was down 6.78% to $0.055. Amarantus BioScience Holdings, Inc., a development-stage biotechnology company, focuses on the discovery and development of drug candidates and diagnostic blood tests to diagnose and treat human diseases in the United States.
Will AMBS Get Buyers Even After The Recent Rally? Find Out Here
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)